STOCKS TELEGRAPH

Tag: MKD

  • Bears Are Right To Worry About Molecular Data (MKD)

    Taking a look at Molecular Data Inc. (NASDAQ: MKD) there is little to marvel at, or even panic over. Its share price alone has been largely stable without deviating too much in the last 3 months. However, taking a broader look at the stock would reveal a plummet of almost 92% in the last 12 months.

    The Deadly Notification by NASDAQ to MKD

    Talks about a possible delisting of Molecular Data has been dominating the discourse surrounding the stock for a few months now. This has understandably contributed to the pessimism surrounding the stock. The notification earlier this year by NASDAQ, communicating compliance failure with a minimum bid price of $1, threatens the stock’s prospects at the exchange. A hearing has been called where the company will make its case before a final decision will eventually be made. The stock’s present price of $0.55 worsens its predicament and has many speculating that delisting may be imminent. Despite this, however, its short float still stands at a modest 7%, indicating that many are choosing to wait and watch developments.

    Molecular Data Future Outlook

    Before the company can focus on a forward path, its present focus remains its fight for survival. Getting delisted on NASDAQ could send MKD crashing down, which would have dire consequences in terms of its financial viability. The stock has already been facing the brunt of Chinese Covid-related headwinds, that have sent even the mightiest of stocks on their knees. A penny stock such as MKD hardly stands a chance to soar in such conditions. Even in the case of a positive result coming from the NASDAQ hearing, the company would need to work on its financial sustainability.

    Conclusion

    MKD is arguably facing one of the worst circumstances and is eagerly hoping for a positive update regarding its NASDAQ non-compliance hearing. Market participants are eagerly watching as MKD has already been heavily driven down in the last year.

  • Why is Molecular Data Inc. (MKD) stock Rallying in the Premarket?

    On March 14, Molecular Data Inc. (MKD) stock was trending in the premarket as it had increased by a good 23.95% at the last check. At the time of writing the volume of the shares exchanged was 4 million while the stock was trading at a price of $0.191 in the premarket. There is no official news or SEC filing from the company to explain the bullish trend.

    In the previous trading session on Friday, the stock remained bearish with a loss of 12.49%. MKD stock closed the session at a value of $0.1541 per share as 11.54 million shares traded.

    The technology-driven platform, Molecular Data Inc. operates a chemical e-commerce business in China through its subsidiaries. Founded in 2013, the company has a market capitalization of $28.16 million with its 164.45 million shares outstanding.

    What is Happening with MKD?

    With the ongoing instability in the market due to the Russia-Ukraine conflict, investors have been placing their bets on market classics like precious metals and basic materials. The inflation pressure and increasing sanctions on Russia resulted in energy stocks being a target. Subsequently, other sectors including healthcare stocks have suffered immensely lately as most plunged to new lows last week. MKD stock shared a similar fate with bearish momentum.

    Although there is no official reason, MKD finally seems to be recovering well. It seems external factors like social media discussions and stock sentiment are responsible for the change of hearts of the investors. After having lost a huge 88.99% last year, the stock currently stands at a year-to-date loss of 29.31%.

    Recent Titles & Awards

    Source: Allbusiness

    On January 19, the company announced receiving the 2021 Digital Service Innovation Enterprise Award. The 2021 Innovation Impact Initiative is launched by CCID, China Electronics Information Industry Research Institute, and Digital Economy Magazine.

    Additionally, on the same day, the company was rated top 8 in the “Digitalization of the plastics industry” list. The “Top 100 list for China’s industrial digitalization in 2021” was released by the Research center of E-commerce and the E-commerce Platform.

    MKD’s Recent Joint Venture

    On December 14, MKD announced entering into an agreement for the formation of a Joint Venture for building supercomputing clusters in North America. Moreover, the new JV had plans for the construction of two plants in the U.S. In addition, the company expects to generate revenue of USD5 million and gross profit of USD4 million from the new business line.

  • Molecular Data Inc. (MKD) stock gains in the Pre-Market: Things you need to know

    Shares of Molecular Data Inc. (MKD) were gaining in Thursday’s pre-market after following the downtrend in the previous open market. MKD stock price saw a jump of 4.81% to reach $1.10 a share at the time of this writing. MKD stock price dropped to $1.04 and down by 7.96% at the previous closing. Let’s try to find the reason behind this rise.

    What’s happening?

    Molecular Data Inc. (MKD) is the leading chemical e-commerce-based platform in the Republic of China. MKD’s rising stock price today captivated the attention of individuals who are looking for some reason. Still, the reality is somewhat different from expectations. We find no particular news by the company today, no earnings report, no analyst upgrades, or upswing targeted MKD stock price to explain the culprit behind this rise. However, Molecular Data did announce some of its recent development in the early days of this month.

    Recent Agreements

    On March 09, 2021, MKD stock signed the supply frame agreement with Anhui Gujing Distillery Co., Ltd for becoming the key supplier of the chemical and biological reagents and laboratory equipment and consumables to expandMKD’s presence in the food and beverage industry. Molecular Data will provide approximately 2 million stock-keeping units (SKUs) to Gujing for its domestic and foreign laboratory brands and suppliers. On the last day, MKD stock announced the MOU for the potential transaction and a stake in the famous brand name in the U.S to strengthen its presence in America.

    On March 05, 2021, Molecular Data entered into the cooperation agreement with Yili Industrial Group Co., pursuant to which the laboratory supplies Mall and centralized procurement platform of MKD would become branches and subsidiaries of Yili Group.

    Conclusion

    So far, so good for MKD stock price, but one should remember that rising stock price despite the absence of reason could not be the base for any decision about the particular stock.MKD stock has shown developments in recent times, and its business model suits the COVID world. In short, individuals eyeing MKD stock have to get the nitty-gritty details of it.

  • Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    Pre-Market Cues: 29 Stocks Roaring for Change On December 24th

    ‎Ocugen Inc. (OCGN) stock plunged -8.85% to $2.37 in the pre-market trading after ‎reporting the appointment of a vaccine scientific advisory board comprised of leading academic and ‎industry experts in the vaccine field.‎

    ‎Sundial Growers Inc. (SNDL), a Drug Manufacturers – Specialty & Generic ‎company, ‎dropped about -3.24% at $0.4838 in pre-market trading Thursday.‎

    ‎Jaguar Health Inc. (NASDAQ: JAGX) shares are trading down -22.43% at $0.83 at the ‎time of writing after signing second agreement for $6 million non-dilutive financing transaction ‎involving the sale of royalty rights related to future Mytesi (Crofelemer) and Lechlemer revenue ‎Sstream. Company’s 52-week ranged between $0.19 to $1.08. Analysts have a consensus price target ‎of $2. ‎

    ‎Onconova Therapeutics Inc. (ONTX) stock moved down -7.92 percent to ‎‎$0.465 ‎in ‎the pre-market trading.‎

    ‎Acasti Pharma Inc. (ACST) tumbled over -4.77% at $0.4095 in pre-market trading ‎today following the announcement from the company that the Company’s management and Board of ‎Directors are unaware of any material change in the Company’s operations that would account for the ‎recent increase in market activity.‎

    ‎FuelCell Energy Inc. (FCEL) lost over -4.55% at $12.81 in pre-‎market ‎trading ‎Thursday ‎December 24, 2020.‎

    ‎Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading down -3.87% at $0.745 ‎at the time of writing after the company announced publication revealing in side-by-side comparison ‎that method using PacBio sequencing ‎detects only 72% of the large structural variants detected by ‎optical Genome Mapping with Saphyr.‎ Company’s 52-week ranged between $0.25 to $1.39. Analysts ‎have a consensus price target of $1.25. ‎

    ‎Marathon Patent Group Inc. (NASDAQ: MARA) shares are trading ‎up ‎‎7.31% ‎at ‎‎$11.6 ‎at the time of writing. Company’s 52-week ranged between $0.35 to ‎‎$14.08. ‎Analysts ‎have ‎a ‎consensus price target of $7.50.‎

    ‎Zomedica Corp. (ZOM) is down more than -2.48% at $0.22 in pre-‎‎‎market ‎hours ‎Thursday December 24, 2020. The stock had jumped over 17.50% to $0.23 in ‎the ‎last ‎trading ‎session.‎

    ‎Nano Dimension Ltd. (NNDM) is up more than 7.18% at $9.4 in pre-‎‎market ‎hours ‎Thursday December 24, 2020. The stock had dropped over -3.41% to $8.77 in the ‎last ‎trading ‎session.‎

    Before the trading started on December 24, 2020, Senseonics Holdings Inc. (SENS) is ‎up 79.29% to reach $1.16 following its declaration of financial and operational business updates. It has ‎been trading in a 52-week range of $0.35 to $1.78.‎

    ‎Corbus Pharmaceuticals Holdings Inc. (CRBP) lost over -2.08% at $1.41 in pre-‎‎market ‎trading Thursday December 24, 2020.‎

    Before the trading started on December 24, 2020, Foresight Autonomous ‎Holdings ‎Ltd. ‎‎(FRSX) is down -20.87% to reach $4.55. It has been trading in a 52-week range ‎of $0.46 ‎to ‎‎$3.40.‎

    ‎Canaan Inc. (CAN) is up more than 2.12% at $3.85 in pre-‎market ‎hours ‎Thursday ‎December 24, 2020. The stock had dropped over -8.94% to $3.77 in the last ‎trading ‎session.‎

    ‎Avinger Inc. (AVGR) stock soared 76.25% to $0.61 in the pre-market trading after ‎reporting results of its annual meeting of stockholders. The most recent rating by Ladenburg ‎Thalmann, on March 09, 2018, is a Buy.‎

    ‎Triterras Inc. (NASDAQ: TRIT) shares are trading up 16.58% at $14.06 ‎at ‎the ‎time ‎of ‎writing. Company’s 52-week ranged between $7.70 to $15.17. Analysts have ‎a ‎consensus ‎price ‎target ‎of $23.‎

    ‎Tantech Holdings Ltd (TANH), a Household & Personal Products ‎company, ‎rose ‎about 3.29% at $1.57 in pre-market trading Thursday.‎

    ‎Tonix Pharmaceuticals Holding Corp. (TNXP) grew over 36.36% at $0.9 in pre-market ‎trading today following the announcement from the firm that it has completed the purchase of an ‎approximately 44-acre site in Hamilton, Montana, for the construction of a vaccine development and ‎commercial scale manufacturing facility. ‎

    ‎Gold Resource Corporation (GORO) stock moved down -6.85 percent to ‎‎$3.4 ‎in ‎the ‎pre-market trading.‎

    ‎Nikola Corporation (NKLA) gained over 1.8% at $15.3 in pre-market trading ‎Thursday December 24, 2020. The company reported, on Wednesday, that Nikola and Republic ‎Services (RSG) have discontinued their collaboration on refuse truck development.‎

    ‎Molecular Data Inc. (MKD) gained over 2.94% at $0.9027 in pre-‎‎‎market ‎trading ‎Thursday December 24, 2020.‎

    ‎Gevo Inc. (GEVO), a Specialty Chemicals company, rose about 1.03% at $2.94 in pre-‎‎‎‎‎‎market trading Thursday.‎

    ‎IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading up 3.9% at $1.6 at the time ‎of writing after reporting that it has set a Managed Services bookings record for the best Q4 in ‎company history. Company’s 52-week ranged between $0.07 to $3.13. IZEA Managed Services ‎Bookings Top 40% Growth in Q4 to Hit Record.‎

    ‎Novan Inc. (NOVN) grew over 6.81% at $0.737 in pre-market trading today.‎

    Before the trading started on December 24, 2020, ReWalk Robotics Ltd. (RWLK) is ‎up 9.2% to reach $1.9. The firm recently revealed that it has donated one of its ReStore Exo-suits to ‎Brooks Rehabilitation, located in Jacksonville, Florida. It has been trading in a 52-week range of $0.41 to ‎‎$2.71.‎

    ‎Inuvo Inc. (AMEX: INUV) shares are trading up 2.16% at $0.52 at the ‎time ‎of ‎writing. ‎Company’s 52-week ranged between $0.09 to $1.11. Analysts have a consensus price ‎target ‎of ‎‎$2.25.‎

    ‎Aurora Mobile Limited (JG) stock soared 8.16% to $4.11 in the pre-market trading ‎following the announcement of a partnership deal with Taikang Life Insurance Co., Ltd., to strengthen ‎smart insurance solutions with AI rechnologies. The most recent rating by Goldman, on March 06, ‎‎2019, is a Neutral.‎

    ‎fuboTV Inc. (FUBO) stock soared 3.73% to $54.55 in the pre-market ‎trading. ‎The ‎most recent rating by BMO Capital Markets, on December 23, 2020, is a Market perform.‎

    ‎Farmmi Inc. (FAMI) is down more than -2.61% at $1.12 in pre-market hours ‎Thursday December 24, 2020. The company recently revealed its sales win to multi-channel ‎customers with over 100 retail stores in China and Canada. The stock had jumped over 1.77% to $1.15 ‎in the last trading session.‎

  • Molecular Data Inc [MKD] Rallies after Bouncing Off Key Support Level

    Molecular Data Inc [MKD] Rallies after Bouncing Off Key Support Level

    Molecular Data Inc [NASDAQ:MKD] was a top performer yesterday after it bounced off a key support level. This is an indicator that investors expect the stock to hold up above this level in the near-term. MKD recently announced that it will be entering into a definitive agreement with Cayman Islands’ exempt YA II PN, Ltd., that is under the management of Yorkville Advisor Global, LP.

    In the agreement, Molecular Data is set to issue and sell convertible debentures worth an aggregate principal of US$5.0 million in a private placement that will be subject to customary closing conditions.

    Issuing and selling of the convertible debentures will be on instalments that will adhere to the following schedule:

    1. Upon signing of the definitive agreement, there will be a sale of convertible debentures worth US$3.0 million.
    2. Upon the filing of a registration statement with the SEC (Securities and Exchange Commission) convertibles debentures worth US$1.0 million will be issues and bought
    • When the SEC declares the registration statement effective, convertible debentures worth US$1.0 million to be issued and bought.

    The convertible debentures issued attract an annual interest rate of 5%. They are set to mature within one year after the issuance date as long as they are not redeemed or converted based on the terms set before the maturity date.

    The purchasing party has the right to convert the convertible debentures in part or entirely at any time, based on the terms of the agreement and upon compliance with those terms. If the purchaser converts the convertible debentures, the selling company will have to deliver to the purchaser American depository shares of the company. Projections show that the initial conversion price will either be the lower of US$1.30 for every ADS unit or 88% of the benchmark price of the Company’s ADSs.

    About Molecular Data Inc

    Molecular Data Inc., is an international technology-driven company that forms part of China’s chemical industry. It helps connect companies in the chemical value chain using integrated and updated solutions. Among the services, the company provides in this industry include financial solutions, warehousing and logistics, e-commerce, and SaaS suite to help facilitate operations within the chemical industry. The e-commerce solutions that the company offers work on an integrated knowledge engine as well as artificial intelligence (AI) capabilities and mainly offer those services on the company’s online platform. The online platform allows for scaling these solutions to unlimited levels. This platform consists of Moku Data WeChat, molbase.cn, molbase.com, and Chemical Community App among other supporting platforms.